These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8540111)

  • 1. High frequency of alloreactive T cells is a consequence of the presentation of many peptides by allogeneic MHC molecules.
    Salom R; Brookes P; Hornick P; Lechler R
    Transplant Proc; 1995 Dec; 27(6):3579. PubMed ID: 8540111
    [No Abstract]   [Full Text] [Related]  

  • 2. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
    Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
    Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
    Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
    J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.
    Ohyama H; Nishimura F; Meguro M; Takashiba S; Murayama Y; Matsushita S
    Cytokine; 2002 Feb; 17(4):175-81. PubMed ID: 11991669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
    Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
    Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
    Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
    J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
    Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
    Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA system, antigen processing and presentation.
    Krensky AM
    Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
    Hansen BE; Andersson EC; Madsen LS; Engberg J; Søndergaard L; Svejgaard A; Fugger L
    Tissue Antigens; 1998 Feb; 51(2):119-28. PubMed ID: 9510368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allogeneic response and tumor immunity.
    Fabre JW
    Nat Med; 2001 Jun; 7(6):649-52. PubMed ID: 11385492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
    Sotiriadou R; Perez SA; Gritzapis AD; Sotiropoulou PA; Echner H; Heinzel S; Mamalaki A; Pawelec G; Voelter W; Baxevanis CN; Papamichail M
    Br J Cancer; 2001 Nov; 85(10):1527-34. PubMed ID: 11720440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
    Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH
    J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.